Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels

Chemoresistance is a major problem in the therapeutic management of pancreatic cancer, concurring to poor clinical outcome. A number of mechanisms have been proposed to explain resistance to gemcitabine, a standard of care for this malignancy, among which is included aberrant miRNA expression. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Panebianco, Concetta, Trivieri, Nadia, Villani, Annacandida, Terracciano, Fulvia, Latiano, Tiziana Pia, Potenza, Adele, Perri, Francesco, Binda, Elena, Pazienza, Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146031/
https://www.ncbi.nlm.nih.gov/pubmed/33925948
http://dx.doi.org/10.3390/biom11050639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146031/
https://www.ncbi.nlm.nih.gov/pubmed/33925948
http://dx.doi.org/10.3390/biom11050639

Ejemplares similares